BiotechTube
Home/Pipeline/Meropenem-Vaborbactam

Meropenem-Vaborbactam

Bacterial Infections

Commercial (in China)Recently Launched in Greater Bay Area

Key Facts

Indication
Bacterial Infections
Phase
Commercial (in China)
Status
Recently Launched in Greater Bay Area
Company
SciClone Pharmaceuticals

About SciClone Pharmaceuticals

A China-based biopharma company commercializing Zadaxin and developing novel oncology and anti-infective therapies.

View full company profile

Therapeutic Areas

OncologyInfectious DiseaseCardiovascular

Other Bacterial Infections Drugs

DrugCompanyPhase
Azithromycin PreparationsCSPC PharmaceuticalCommercial
Penem PreparationsCSPC PharmaceuticalCommercial
Various Penicillin/Cephalosporin ProductsCSPC PharmaceuticalCommercial
Nemonoxacin Malate CapsulesZhejiang MedicineCommercial
Generic Portfolio Expansion - Anti-infectivesAlkaloid AD SkopjeRegulatory Submission
Clindamycin Phosphate InjectionViwitCommercial
Levofloxacin Hydrochloride InjectionViwitCommercial
Vibativ® (telavancin)Cleo Life SciencesApproved
Penicillin V APIBiotikaCommercial
Sterile Injectable Antibiotics PortfolioSteripharmaApproved
Oral AntibioticDawah PharmaceuticalsANDA Filed/Pre-approval
XAB05/XAB06XenotheraPreclinical